Inversely, the application of the HDAC-inhibitor butyrate to oral squamous cell carcinoma cells with initially high membrane-bound E-cadherin promoted E-cadherin translocation to the cytoplasm [25]. The gene discussed is HDAC9; the disease is oral cavity squamous cell carcinoma.